Stockscreener 앱 받기
146.12
1.87%
2.68
전일 마감가:
$143.44
열려 있는:
$144.52
하루 거래량:
5.38M
Relative Volume:
0.73
시가총액:
$181.18B
수익:
$29.79B
순이익/손실:
$9.22B
주가수익비율:
19.88
EPS:
7.3494
순현금흐름:
$10.23B
1주 성능:
+5.61%
1개월 성능:
+12.16%
6개월 성능:
-3.49%
1년 성능:
+25.81%
1일 변동 폭
$143.50
$147.91
1주일 범위
$136.63
$148.97
52주 변동 폭
$108.46
$157.29
길리어드 사이언스 Stock (GILD) Company Profile
명칭
Gilead Sciences Inc
전화
(650) 574-3000
주소
333 LAKESIDE DR, FOSTER CITY, CA
Compare GILD vs LLY, JNJ, ABBV, MRK, NVS
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GILD
Gilead Sciences Inc
|
146.12 | 177.86B | 29.79B | 9.22B | 10.23B | 7.3494 |
LLY
Lilly Eli Co
|
1,255.40 | 1.11T | 72.25B | 25.28B | 10.37B | 27.78 |
JNJ
Johnson Johnson
|
270.24 | 644.33B | 97.93B | 21.04B | 17.80B | 8.6278 |
ABBV
Abbvie Inc
|
264.96 | 462.68B | 62.82B | 3.60B | 19.98B | 2.0274 |
MRK
Merck Co Inc
|
152.55 | 367.58B | 65.51B | 8.93B | 14.12B | 3.5532 |
NVS
Novartis Ag Adr
|
158.86 | 296.97B | 54.66B | 13.58B | 16.05B | 7.0171 |
길리어드 사이언스 Stock (GILD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-10 | 개시 | Jefferies | Buy |
| 2026-02-20 | 개시 | Barclays | Equal Weight |
| 2026-02-11 | 재확인 | Needham | Buy |
| 2026-01-07 | 재개 | UBS | Buy |
| 2025-11-24 | 재개 | Truist | Buy |
| 2025-11-13 | 개시 | Scotiabank | Sector Outperform |
| 2025-08-19 | 업그레이드 | Daiwa Securities | Neutral → Outperform |
| 2025-08-08 | 업그레이드 | Truist | Hold → Buy |
| 2025-07-25 | 업그레이드 | Needham | Hold → Buy |
| 2025-04-22 | 재개 | Cantor Fitzgerald | Overweight |
| 2025-03-04 | 재확인 | Oppenheimer | Outperform |
| 2025-02-18 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2025-02-13 | 업그레이드 | DZ Bank | Hold → Buy |
| 2025-01-10 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-12-10 | 재개 | BofA Securities | Buy |
| 2024-11-15 | 개시 | Wolfe Research | Outperform |
| 2024-11-14 | 개시 | Citigroup | Buy |
| 2024-11-08 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2024-10-21 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-10-17 | 개시 | Bernstein | Outperform |
| 2024-10-07 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-07-08 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2024-05-01 | 재확인 | Maxim Group | Buy |
| 2024-04-24 | 업그레이드 | HSBC Securities | Reduce → Hold |
| 2024-02-22 | 다운그레이드 | Truist | Buy → Hold |
| 2023-11-09 | 개시 | Deutsche Bank | Hold |
| 2023-09-08 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-09-06 | 개시 | HSBC Securities | Reduce |
| 2023-07-24 | 재확인 | Barclays | Equal Weight |
| 2023-05-16 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2023-04-28 | 재개 | Piper Sandler | Overweight |
| 2023-01-03 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-12-13 | 재개 | BofA Securities | Neutral |
| 2022-12-09 | 다운그레이드 | DZ Bank | Buy → Hold |
| 2022-10-31 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2022-10-28 | 재확인 | BMO Capital Markets | Market Perform |
| 2022-10-28 | 재확인 | Cowen | Outperform |
| 2022-10-28 | 재확인 | JP Morgan | Overweight |
| 2022-10-28 | 재확인 | Jefferies | Buy |
| 2022-10-28 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-10-28 | 재확인 | RBC Capital Mkts | Outperform |
| 2022-10-28 | 업그레이드 | Truist | Hold → Buy |
| 2022-10-28 | 재확인 | Wells Fargo | Equal Weight |
| 2022-10-04 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2022-07-13 | 개시 | Cantor Fitzgerald | Neutral |
| 2022-05-23 | 개시 | SVB Leerink | Mkt Perform |
| 2022-02-28 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2022-02-02 | 재확인 | BMO Capital Markets | Outperform |
| 2022-02-02 | 재확인 | BofA Securities | Neutral |
| 2022-02-02 | 재확인 | RBC Capital Mkts | Outperform |
| 2022-02-02 | 재확인 | Truist | Hold |
| 2022-02-02 | 재확인 | Wells Fargo | Equal Weight |
| 2022-01-28 | 업그레이드 | Argus | Hold → Buy |
| 2022-01-06 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-09 | 재개 | Wells Fargo | Equal Weight |
| 2021-12-06 | 개시 | Goldman | Neutral |
| 2021-11-19 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2021-11-19 | 재개 | Piper Sandler | Neutral |
| 2021-10-20 | 재개 | Cowen | Outperform |
| 2021-07-30 | 재확인 | BMO Capital Markets | Market Perform |
| 2021-07-30 | 재확인 | RBC Capital Mkts | Outperform |
| 2021-04-01 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2021-03-30 | 업그레이드 | Redburn | Neutral → Buy |
| 2021-01-19 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2021-01-04 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-11-03 | 재개 | Morgan Stanley | Equal-Weight |
| 2020-10-28 | 개시 | UBS | Neutral |
| 2020-09-30 | 재개 | Jefferies | Buy |
| 2020-09-15 | 업그레이드 | Maxim Group | Hold → Buy |
| 2020-07-31 | 재확인 | Credit Suisse | Neutral |
| 2020-07-31 | 재확인 | Morgan Stanley | Equal-Weight |
| 2020-07-31 | 재확인 | Piper Sandler | Overweight |
| 2020-07-31 | 재확인 | RBC Capital Mkts | Outperform |
| 2020-07-31 | 재확인 | SunTrust | Hold |
| 2020-07-31 | 재확인 | Wells Fargo | Equal Weight |
| 2020-07-20 | 업그레이드 | Credit Suisse | Underperform → Neutral |
| 2020-06-03 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2020-05-26 | 업그레이드 | SunTrust | Sell → Hold |
| 2020-05-01 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-05-01 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2020-05-01 | 다운그레이드 | SunTrust | Hold → Sell |
| 2020-04-27 | 다운그레이드 | UBS | Buy → Neutral |
| 2020-04-20 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2020-04-20 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-04-17 | 다운그레이드 | CFRA | Hold → Sell |
모두보기
길리어드 사이언스 주식(GILD)의 최신 뉴스
Gilead Sciences director Jeffrey Bluestone sells $725,077 in stock - Investing.com
Gilead Sciences director Jeffrey Bluestone sells $725,077 in stock By Investing.com - Investing.com UK
Gilead Sciences (NASDAQ:GILD) Director Sells 5,000 Shares of Stock - MarketBeat
Gilead Sciences (GILD) director sells 5,000 shares near $146 - Stock Titan
Portfolio Design Labs LLC Takes $1.29 Million Position in Gilead Sciences, Inc. $GILD - MarketBeat
PCM Encore LLC Buys Shares of 7,399 Gilead Sciences, Inc. $GILD - MarketBeat
Vise Technologies Inc. Takes $15.17 Million Position in Gilead Sciences, Inc. $GILD - MarketBeat
14,265 Shares in Gilead Sciences, Inc. $GILD Purchased by OVERSEA CHINESE BANKING Corp Ltd - MarketBeat
Trillium Asset Management LLC Makes New Investment in Gilead Sciences, Inc. $GILD - MarketBeat
Allworth Financial LP Invests $5.96 Million in Gilead Sciences, Inc. $GILD - MarketBeat
Altman Advisors Inc. Takes Position in Gilead Sciences, Inc. $GILD - MarketBeat
B. Metzler seel. Sohn & Co. AG Purchases New Position in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead (NASDAQ: GILD) director to sell 5,000 shares in 2026 - Stock Titan
Gilead Sciences Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Gilead Sciences Stock Surges 11%, With A 7-Day Winning Spree - Trefis
Gilead Sciences Stock Climbs 11% On A 7-Day Winning Streak - Trefis
Zacks Research Expects Higher Earnings for Gilead Sciences - MarketBeat
Westport Asset Management Inc. Acquires Shares of 10,000 Gilead Sciences, Inc. $GILD - MarketBeat
Johnson Financial Group Inc. Invests $2.12 Million in Gilead Sciences, Inc. $GILD - MarketBeat
Tocqueville Asset Management L.P. Purchases Shares of 59,933 Gilead Sciences, Inc. $GILD - MarketBeat
NewEdge Wealth LLC Takes $95.26 Million Position in Gilead Sciences, Inc. $GILD - MarketBeat
Knuff & Co LLC Buys Shares of 17,641 Gilead Sciences, Inc. $GILD - MarketBeat
E Fund Management Co. Ltd. Acquires Shares of 53,836 Gilead Sciences, Inc. $GILD - MarketBeat
Edmond DE Rothschild Holding S.A. Purchases New Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Great Lakes Advisors LLC Buys Shares of 62,450 Gilead Sciences, Inc. $GILD - MarketBeat
59,974 Shares in Gilead Sciences, Inc. $GILD Purchased by Abacus FCF Advisors LLC - MarketBeat
Foster & Motley Inc. Takes Position in Gilead Sciences, Inc. $GILD - MarketBeat
Diversify Advisory Services LLC Invests $1.82 Million in Gilead Sciences, Inc. $GILD - MarketBeat
Does Gilead (GILD) Pairing With Nucleai Reveal a Deeper Shift in Its Oncology Strategy? - Yahoo Finance
Gilead SciencesGISStock Price & News - The Motley Fool
Publicis wins Gilead Sciences' US media account - Ad Age
Gilead Sciences Inc Stock (GILD) Moved Up by 3.66% on Aug 19: A Full Analysis - TradingKey
Gilead Sciences (GILD) CFO Andrew Dickinson Sells 3,000 Shares - GuruFocus
Zacks Research Forecasts Higher Earnings for Gilead Sciences - MarketBeat
Invesco Nasdaq Biotech vs. Invesco Pharma: How Do These ETFs Stack Up? - The Motley Fool
Meeder Advisory Services Inc. Invests $4.42 Million in Gilead Sciences, Inc. $GILD - MarketBeat
M. Kulyk & Associates LLC Buys New Position in Gilead Sciences, Inc. $GILD - MarketBeat
Pallas Capital Advisors LLC Invests $940,000 in Gilead Sciences, Inc. $GILD - MarketBeat
Great Lakes Advisors LLC Makes New $127.25 Million Investment in Gilead Sciences, Inc. $GILD - MarketBeat
13,735 Shares in Gilead Sciences, Inc. $GILD Purchased by Empirical Asset Management LLC - MarketBeat
840,400 Shares in Gilead Sciences, Inc. $GILD Purchased by Danske Bank A S - MarketBeat
Gilead Sciences Insider Sold Shares Worth $3,853,908, According to a Recent SEC Filing - marketscreener.com
Gilead Sciences CFO Andrew Dickinson sells $415k in shares - Investing.com
Andrew Dickinson Sells 3,000 Shares of Gilead Sciences (NASDAQ:GILD) Stock - MarketBeat
Gilead Sciences chief comm & corp aff officer sells $3.85m stock - Investing.com
Gilead Sciences (NASDAQ:GILD) Insider Johanna Mercier Sells 28,000 Shares of Stock - MarketBeat
Gilead (NASDAQ: GILD) CFO sells shares under 10b5-1 plan - Stock Titan
Gilead (NASDAQ: GILD) CCO sells 28,000 shares under 10b5-1 plan - Stock Titan
Gilead Sciences Inc (GILD) Stock Up 3.2% but GF Value Says Overv - GuruFocus
Gilead Sciences Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Is Gilead's Expanding HIV Portfolio a Growth Catalyst? - TradingView
길리어드 사이언스 (GILD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.01%
자본화:
|
볼륨(24시간):